Related Experiment Video
Updated: Jan 14, 2026

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Global Cancer Imaging Access: Addressing Barriers and Harnessing Innovations
Hero K Hussain1, Radhika Rajeev1, Kristen K DeStigter2
1Department of Radiology, University of Michigan Medical School, 1500 E Medical Center Dr, Ann Arbor, MI 48109.
None:
The global cancer burden is increasing, with disproportionate morbidity and mortality in low- and middle-income countries. Imaging is essential for cancer diagnosis, staging, and follow-up, yet access in these settings remains poor. Barriers include insufficient availability of appropriate equipment, shortages of trained personnel, limited interventional services, and socioeconomic constraints. This review examines these barriers and challenges in global access to imaging for common cancers such as breast, lung, prostate, and hepatocellular carcinoma. Potential solutions are discussed, including innovations such as fit-for-purpose imaging hardware, artificial intelligence-assisted image interpretation, and governmental, policy, and international initiatives aimed at improving cancer imaging access in low- and middle-income countries. Keywords: Multimodal Applications, CT, Ultrasound, MRI, Artificial Intelligence, PET/CT © RSNA, 2025.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...

